[1]
|
Parisi, R., Iskandar, I.Y.K., Kontopantelis, E., Augustin, M., Griffiths, C.E.M., Ashcroft, D.M. and Global Psoriasis Atlas (2020) National, Regional, and Worldwide Epidemiology of Psoriasis: Systematic Analysis and Modelling Study. BMJ, 369, M1590. https://doi.org/10.1136/bmj.m1590
|
[2]
|
Griffiths, C.E. and Barker, J.N. (2007) Pathogenesis and Clinical Features of Psoriasis. The Lancet, 370, 263-271. https://doi.org/10.1016/S0140-6736(07)61128-3
|
[3]
|
Boehncke, W.H. and Schön, M.P. (2015) Psoriasis. The Lancet, 386, 983-994. https://doi.org/10.1016/S0140-6736(14)61909-7
|
[4]
|
Younossi, Z.M., Koenig, A.B., Abdelatif, D., Fazel, Y., Henry, L. and Wymer, M. (2016) Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes. Hepatology, 64, 73-84. https://doi.org/10.1002/hep.28431
|
[5]
|
Younossi, Z.M. (2019) Non-Alcoholic Fatty Liver Disease—A Global Public Health Perspective. Journal of Hepatology, 70, 531-544. https://doi.org/10.1016/j.jhep.2018.10.033
|
[6]
|
Candia, R., Ruiz, A., Torres-Robles, R., Chávez-Tapia, N., Méndez-Sánchez, N. and Arrese, M. (2015) Risk of Non-Alcoholic Fatty Liver Disease in Patients with Psoriasis: A Systematic Review and Meta-Analysis. Journal of the European Academy of Dermatology and Venereology, 29, 656-662. https://doi.org/10.1111/jdv.12847
|
[7]
|
Gau, S.Y., Huang, K.H., Lee, C.H., Kuan, Y.H., Tsai, T.H. and Lee, C.Y. (2022) Bidirectional Association between Psoriasis and Nonalco-Holic Fatty Liver Disease: Real-World Evidence from Two Longitudinal Cohort Studies. Frontiers in Immunology, 13, Article ID: 840106. https://doi.org/10.3389/fimmu.2022.840106
|
[8]
|
Davey, S.G. and Hemani, G. (2014) Mendelian Randomization: Genetic Anchors for Causal Inference in Epidemiological Studies. Human Molecular Genetics, 23, R89-R98. https://doi.org/10.1093/hmg/ddu328
|
[9]
|
Chen, L., Fan, Z., Sun, X., et al. (2022) Mendelian Randomization Rules out Causation between Inflammatory Bowel Disease and Non-Alcoholic Fatty Liver Disease. Frontiers in Pharmacology, 13, Article ID: 891410. https://doi.org/10.3389/fphar.2022.891410
|
[10]
|
Yavorska, O.O. and Burgess, S. (2017) Mendelian Randomization: An R Package for Performing Mendelian Randomization Analyses Using Summarized Data. International Journal of Epidemiology, 46, 1734-1739. https://doi.org/10.1093/ije/dyx034
|
[11]
|
Pierce, B.L. and Burgess, S. (2013) Efficient Design for Mendelian Randomization Studies: Subsample and 2-Sample Instrumental Variable Estimators. American Journal of Epidemiology, 178, 1177-1184. https://doi.org/10.1093/aje/kwt084
|
[12]
|
Burgess, S. and Thompson, S.G. (2017) Interpreting Findings from Mendelian Randomization Using the MR-Egger Method. European Journal of Epidemiology, 32, 377-389. https://doi.org/10.1007/s10654-017-0255-x
|
[13]
|
Egger, M., Smith, G.D. and Phillips, A.N. (1997) Meta-Analysis: Principles and Procedures. BMJ, 315, 1533-1537. https://doi.org/10.1136/bmj.315.7121.1533
|
[14]
|
Verbanck, M., Chen, C.Y., Neale, B., et al. (2018) Detection of Widespread Horizontal Pleiotropy in Causal Relationships Inferred from Mendelian Randomization between Complex Traits and Diseases. Nature Genetics, 50, 693-698. https://doi.org/10.1038/s41588-018-0099-7
|
[15]
|
Bowden, J., Del Greco, M.F., Minelli, C., et al. (2016) Assessing the Suitability of Summary Data for Two-Sample Mendelian Ran-Domization Analyses Using MR-Egger Regression: The Role of the I2 Statistic. International Journal of Epidemiology, 45, 1961-1974. https://doi.org/10.1093/ije/dyw220
|
[16]
|
Higgins, J.P. and Thompson, S.G. (2002) Quantifying Heterogeneity in a Meta-Analysis. Statistics in Medicine, 21, 1539-1558. https://doi.org/10.1002/sim.1186
|
[17]
|
Burgess, S., Thompson, S.G. and CRP CHD Genetics Collaboration (2011) Avoiding Bias from Weak Instruments in Mendelian Randomization Studies. International Journal of Epidemiology, 40, 755-764. https://doi.org/10.1093/ije/dyr036
|
[18]
|
Näslund-Koch, C., Bojesen, S.E., Gluud, L.L., Skov, L. and Vedel-Krogh, S. (2022) Non-Alcoholic Fatty Liver Disease Is Not a Causal Risk Factor for Psoriasis: A Mendelian Randomization Study of 108,835 Individuals. Frontiers in Immunology, 13, Article ID: 1022460. https://doi.org/10.3389/fimmu.2022.1022460
|
[19]
|
Mantovani, A., Gisondi, P., Lonardo, A. and Targher, G. (2016) Relationship between Non-Alcoholic Fatty Liver Disease and Psoriasis: A Novel Hepato-Dermal Axis? International Journal of Molecular Sciences, 17, Article No. 217. https://doi.org/10.3390/ijms17020217
|
[20]
|
Heitmann, J., Frings, V.G., Geier, A., Goebeler, M. and Kerstan, A. (2021) Non-Alcoholic Fatty Liver Disease and Psoriasis—Is There a Shared Proinflammatory Network? Journal der Deutschen Dermatologischen Gesellschaft, 19, 517-528. https://doi.org/10.1111/ddg.14425
|
[21]
|
Diehl, A.M. (2004) Tumor Necrosis Factor and Its Potential Role in Insulin Resistance and Nonalcoholic Fatty Liver Disease. Clinical Liver Disease, 8, 619-638. https://doi.org/10.1016/j.cld.2004.04.012
|
[22]
|
Xue, K., Liu, H., Jian, Q., Liu, B., Zhu, D., Zhang, M., Gao, L. and Li, C. (2013) Leptin Induces Secretion of Pro-Inflammatory Cytokines by Human Keratinocytes in Vitro—A Possible Reason for Increased Severity of Psoriasis in Patients with a High Body Mass Index. Experimental Dermatology, 22, 406-410. https://doi.org/10.1111/exd.12162
|
[23]
|
Neuschwander-Tetri, B.A. (2010) Hepatic Lipotoxicity and the Pathogenesis of Nonalcoholic Steatohepatitis: The Central Role of Nontriglyceride Fatty Acid Metabolites. Hepatology, 52, 774-788. https://doi.org/10.1002/hep.23719
|
[24]
|
Carter-Kent, C., Zein, N.N. and Feldstein, A.E. (2008) Cytokines in the Pathogenesis of Fatty Liver and Disease Progression to Steato-Hepatitis: Implications for Treatment. American Journal of Gastroenterology, 103, 1036-1042. https://doi.org/10.1111/j.1572-0241.2007.01709.x
|
[25]
|
Byrne, C.D. and Targher, G. (2015) NAFLD: A Multisystem Disease. Journal of Hepatology, 62, S47-S64. https://doi.org/10.1016/j.jhep.2014.12.012
|
[26]
|
Prussick, R.B. and Miele, L. (2018) Nonalcoholic Fatty Liver Disease in Patients with Psoriasis: A Consequence of Systemic Inflammatory Burden? British Journal of Dermatology, 179, 16-29. https://doi.org/10.1111/bjd.16239
|
[27]
|
Wijarnpreecha, K., Aby, E.S., Ahmed, A. and Kim, D. (2021) Evaluation and Management of Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease. Clinical and Molecular Hepatology, 27, 221-235. https://doi.org/10.3350/cmh.2020.0239
|
[28]
|
Byrne, C.D. and Targher, G. (2014) Ectopic Fat, Insulin Resistance, and Nonalcoholic Fatty Liver Disease: Implications for Cardiovascular Disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 34, 1155-1161. https://doi.org/10.1161/ATVBAHA.114.303034
|
[29]
|
Stefan, N. and Häring, H.U. (2013) The Role of Hepatokines in Metabolism. Nature Reviews Endocrinology, 9, 144-152. https://doi.org/10.1038/nrendo.2012.258
|